v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024       31,050,448 0      
Beginning balance at Dec. 31, 2024 $ 41,386,226     $ 31,050 $ 0 $ 265,650,362 $ 0 $ (224,295,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs (in shares)       4,836,804        
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs 13,676,667     $ 4,837   13,671,830    
Issuance of common stock through employee stock purchase plan (in shares)       98,450        
Issuance of common stock through employee stock purchase plan 133,892     $ 98   133,794    
Stock-based compensation expense 1,692,267         1,692,267    
Net loss (15,046,132)             (15,046,132)
Ending balance (in shares) at Mar. 31, 2025       35,985,702 0      
Ending balance at Mar. 31, 2025 41,842,920     $ 35,985 $ 0 281,148,253 0 (239,341,318)
Beginning balance (in shares) at Dec. 31, 2024       31,050,448 0      
Beginning balance at Dec. 31, 2024 41,386,226     $ 31,050 $ 0 265,650,362 0 (224,295,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (29,480,012)              
Ending balance (in shares) at Jun. 30, 2025       35,987,306 0      
Ending balance at Jun. 30, 2025 28,936,037     $ 35,987 $ 0 282,675,249 0 (253,775,199)
Beginning balance (in shares) at Mar. 31, 2025       35,985,702 0      
Beginning balance at Mar. 31, 2025 41,842,920     $ 35,985 $ 0 281,148,253 0 (239,341,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)       1,604        
Issuance of common stock upon exercise of stock options 2,055     $ 2   2,053    
Stock-based compensation expense 1,524,943         1,524,943    
Net loss (14,433,881)             (14,433,881)
Ending balance (in shares) at Jun. 30, 2025       35,987,306 0      
Ending balance at Jun. 30, 2025 28,936,037     $ 35,987 $ 0 282,675,249 0 (253,775,199)
Beginning balance (in shares) at Dec. 31, 2025   64,648,230 0 64,648,230 0      
Beginning balance at Dec. 31, 2025 218,483,968     $ 64,648 $ 0 498,658,072 81,332 (280,320,084)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)       4,696        
Issuance of common stock upon exercise of stock options 10,435     $ 5   10,430    
Issuance of common stock through employee stock purchase plan (in shares)       35,989        
Issuance of common stock through employee stock purchase plan 170,325     $ 36   170,289    
Stock-based compensation expense 1,636,675         1,636,675    
Net loss (13,460,895)             (13,460,895)
Other comprehensive loss (322,337)           (322,337)  
Ending balance (in shares) at Mar. 31, 2026       64,688,915 0      
Ending balance at Mar. 31, 2026 206,518,171     $ 64,689 $ 0 500,475,466 (241,005) (293,780,979)
Beginning balance (in shares) at Dec. 31, 2025   64,648,230 0 64,648,230 0      
Beginning balance at Dec. 31, 2025 $ 218,483,968     $ 64,648 $ 0 498,658,072 81,332 (280,320,084)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares) 13,183              
Net loss $ (30,731,322)              
Ending balance (in shares) at Jun. 30, 2026   64,697,402 0 64,697,402 0      
Ending balance at Jun. 30, 2026 190,735,026     $ 64,697 $ 0 502,127,975 (406,240) (311,051,406)
Beginning balance (in shares) at Mar. 31, 2026       64,688,915 0      
Beginning balance at Mar. 31, 2026 206,518,171     $ 64,689 $ 0 500,475,466 (241,005) (293,780,979)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)       8,487        
Issuance of common stock upon exercise of stock options 24,608     $ 8   24,600    
Stock-based compensation expense 1,627,909         1,627,909    
Net loss (17,270,427)             (17,270,427)
Other comprehensive loss (165,235)           (165,235)  
Ending balance (in shares) at Jun. 30, 2026   64,697,402 0 64,697,402 0      
Ending balance at Jun. 30, 2026 $ 190,735,026     $ 64,697 $ 0 $ 502,127,975 $ (406,240) $ (311,051,406)